Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation

NCT07668232 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

South Valley University